REctus Sheath Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Acute PainPostoperative Pain, Acute
Interventions
DRUG

1.0% lidocaine with epinephrine (1:100,000)

"The block will be performed by advancing the needle into the posterior rectus sheath compartment, with the local anesthetic deposited posterior to the rectus abdominis muscle and anterior to the posterior rectus sheath.~Drug: 20 mL injection of 1.0% lidocaine with epinephrine (1:100,000) on each side (40mL total/subject)"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT07068243 - REctus Sheath Trial | Biotech Hunter | Biotech Hunter